Live feed08:00:00·13mPRReleasevia QuantisnowPDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA OncologyByQuantisnow·Wall Street's wire, on your screen.PDSB· PDS Biotechnology CorporationHealth Care
